Evidence map›Paper›PMID 21245316›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation.

Eric J Gapud, Yair Dorsett, Bu Yin, Elsa Callen, Andrea Bredemeyer, Grace K Mahowald, Kazuo Q Omi, Laura M Walker, Jeffrey J Bednarski, Peter J McKinnon and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Phosphorylation of DNA-PKcs at the S2056 cluster ensures efficient and productive lymphocyte development in XLF-deficient mice.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Nemo-Dependent, ATM-Mediated Signals from RAG DNA Breaks atJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  11. Review
  12. DNA Damage Response and Repair in Adaptive Immunity.Frontiers in cell and developmental biology · 2022
    Review
  13. Review
  14. Review
  15. Review
  16. Checkpoint Responses to DNA Double-Strand Breaks.Annual review of biochemistry · 2020
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Eric J GapudDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA.
Yair Dorsett
Bu Yin
Elsa Callen
Andrea Bredemeyer
Grace K Mahowald
Kazuo Q Omi
Laura M Walker
Jeffrey J Bednarski
Peter J McKinnon
Craig H Bassing
Andre Nussenzweig
Barry P Sleckman
Washington University in St. Louis · USChildren's Hospital of Philadelphia · USNational Cancer Institute · USNational Institutes of Health · USSt. Jude Children's Research Hospital · USUniversity of Pennsylvania · US

Funding

The DNA Damage Response and Tumorigenesis in the BrainP01CA096832 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BAKER, SUZANNE J. · 2003 to 2025
$38.0M
ATM and DNA Damage in the Nervous SystemR01NS037956 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MCKINNON, PETER J · 1998 to 2022
$7.6M
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENTR01AI047829 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2000 to 2021
$7.0M
ATM FUNCTION DURING V(D)J RECOMBINATIONR01AI074953 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2009 to 2023
$5.9M
Training Program in Development HematologyT32HD007499 · NICHD · WASHINGTON UNIVERSITY · PI RUBIN, JOSHUA B · 1999 to 2019
$2.3M
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKSR01CA136470 · NCI · WASHINGTON UNIVERSITY · PI BASSING, CRAIG H, SLECKMAN, BARRY P · 2009 to 2013
$1.6M
Molecular Pathways in Suppression and Development of T Lineage LymphomasR01CA125195 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H · 2007 to 2011
$1.6M
NCI NIH HHS CA096832NCI NIH HHS CA125195NCI NIH HHS CA136470NCI NIH HHS P01 CA096832NCI NIH HHS R01 CA125195NCI NIH HHS R01 CA136470NIAID NIH HHS AI074953NIAID NIH HHS AI47829NIAID NIH HHS R01 AI047829NIAID NIH HHS R01 AI074953NICHD NIH HHS T32 HD007499NINDS NIH HHS R01 NS037956
6 · The paper itself

Abstract

Lymphocyte antigen receptor gene assembly occurs through the process of V(D)J recombination, which is initiated when the RAG endonuclease introduces DNA DSBs at two recombining gene segments to form broken DNA coding end pairs and signal end pairs. These paired DNA ends are joined by proteins of the nonhomologous end-joining (NHEJ) pathway of DSB repair to form a coding joint and signal joint, respectively. RAG DSBs are generated in G1-phase developing lymphocytes, where they activate the ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases to orchestrate diverse cellular DNA damage responses including DSB repair. Paradoxically, although Atm and DNA-PKcs both function during coding joint formation, Atm appears to be dispensible for signal joint formation; and although some studies have revealed an activity for DNA-PKcs during signal joint formation, others have not. Here we show that Atm and DNA-PKcs have overlapping catalytic activities that are required for chromosomal signal joint formation and for preventing the aberrant resolution of signal ends as potentially oncogenic chromosomal translocations.

Indexed as

ChromosomesAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsDNA-Activated Protein KinaseDNA-Binding ProteinsMiceMice, SCIDNuclear ProteinsProtein Serine-Threonine KinasesTumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseCell Cycle ProteinsDNA-Activated Protein KinaseDNA-Binding ProteinsNuclear ProteinsPrkdc protein, mouseProtein Serine-Threonine KinasesTumor Suppressor Proteins

Identifiers

PMID21245316
PMCPMC3033293
OpenAlexW2048421417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.